The Glaucoma and Retinopathy Screening Study
NCT06882356
This study is recruiting at 6 US sites in 1 state, according to its ClinicalTrials.gov record last updated .
Summary
The goal of this clinical trial is to learn if a new screening approach including an artificial intelligence algorithm that analyzes fundus photographs, measurement of eye pressure and visual field testing works to screen for glaucoma. Participants will: Have an image of their fundus (back of the eye) taken as part of their diabetic eye screening Have a measurement of their eye pressure If needed, have a test of their side vision using a headset
Shortened from the sponsor's brief summary. View official record on ClinicalTrials.gov
Conditions studied
- Glaucoma
Eligibility basics and study details
- Study type
- Interventional
- Phase
- Not applicable
- Ages
- 40 years and older
- Sex
- All
- Healthy volunteers
- Not accepted
- Sponsor
- Massachusetts Eye and Ear Infirmary
- Last updated on ClinicalTrials.gov
- August 27, 2026
These are the basic criteria only. The full inclusion and exclusion criteria are on the official record, and the study team decides who can take part.
US recruiting sites
Massachusetts · 6
- Brigham and Women's Primary Care Associates of Longwood · Boston, MA
- Massachusetts General Hospital Broadway Primary Care-Revere · Boston, MA
- Massachusetts General Hospital Internal Medicine Associates · Boston, MA
- MGH Chelsea HealthCare Center · Chelsea, MA
- NSPG Lynn · Lynn, MA
- NSPG Saugus · Saugus, MA
Source: ClinicalTrials.gov, data processed . Recruiting US sites filtered by distance and site status; summaries shortened.